Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast cancer prevention.

J Russo1, G Balogh, I H Russo

  • 1Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, PA, USA.

Climacteric : the Journal of the International Menopause Society
|October 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial.

ESMO open·2021
Same author

Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2012
Same author

Genome scanning using endogenous LTR-like elements for rapid DNA-fingerprinting of breast-cancer and transformed human breast epithelial-cells.

International journal of oncology·2011
Same author

Mammary-derived growth inhibitor (MDGI) cloned from human breast epithelial cells is expressed in fully differentiated lobular structures.

International journal of oncology·2011
Same author

Microsatellite instability of D17S513 on chromosome 17 is associated with progression of breast cancer.

International journal of oncology·2011
Same author

Reentrant phase diagram of network fluids.

Physical review letters·2011

Early first full-term pregnancy creates a genomic signature in breast tissue, reducing cancer susceptibility. This signature, identified through gene expression and protein analysis, marks a shift from cancer-prone to cancer-refractory stem cells.

Area of Science:

  • Oncology
  • Genomics
  • Preventive Medicine

Background:

  • Breast cancer susceptibility is linked to stem cell populations.
  • Early pregnancy induces protective genomic changes in breast tissue.
  • Identifying biomarkers for cancer risk reduction is crucial.

Purpose of the Study:

  • To identify the genomic signature associated with early pregnancy-induced breast cancer risk reduction.
  • To characterize the cellular and molecular changes in breast tissue after early pregnancy.
  • To explore the potential of this signature as a biomarker and therapeutic target.

Main Methods:

  • Case-control study comparing gene expression profiles in normal breast tissue.
  • Analysis of genomic signatures in nulliparous and parous postmenopausal women.

Related Experiment Videos

  • ELISA assay to detect signature-related proteins in plasma.

    • Main Results:

    • Early first full-term pregnancy induces a specific genomic signature (Stem Cell 2) in postmenopausal breast tissue.
    • This signature is associated with a shift from cancer-susceptible (Stem Cell 1) to cancer-refractory stem cells.
    • Proteins encoded by the signature genes were detected in plasma.

    Conclusions:

    • The genomic signature of early pregnancy serves as a biomarker for reduced breast cancer risk.
    • This represents a novel preventive strategy, distinct from traditional chemoprevention.
    • Clinical trials are underway to validate recombinant human chorionic gonadotropin (r-hCG) for inducing this protective signature.